undamentalytics Newsletter
Sign in

Ardent Health, Inc. income statement

In fiscal 2025, Ardent Health, Inc. reported revenue of $6.32bn, up 6.0% on the year before and net income of $136m, or $0.96 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue5,1305,4095,9666,3246,406
General and administrative75115132141183
Income before tax311152363286208
Income tax4623635639
Net income1895421013678
Diluted EPS$1.50$0.43$1.58$0.96$0.55
Diluted shares (average)126m126m133m141m142m

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ARDT vs EHCARDT vs CYHARDT vs MDARDT vs THC

More: Hospitals stocks compared, Health Care sector, rankings of US companies

Figures from Ardent Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ardent Health, Inc.